INVENT Endorsed THEIA Study (Advanced Diagnostic Management of Suspected Recurrent Ipsilateral Deep Vein Thrombosis of the Leg with Magnetic Resonance Direct Thrombus Imaging (MRDTI)) recruited 7 new patients in December 2018 - increasing the total recruitment numbers to 287 of 305 globally! The study is expected to complete recruitment in February 2019. See study information.